Recce Ltd has released a press release.
Recce moves closer to clinical study application
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Operational Update
- Data from large animal study shows RECCE 327 well tolerated
- Appendix 4D and Interim Financial Statements
- Microscopy Images of its Synthetic Antibiotic in Action Dest
- Recce to suspend anti-cancer program
Later from Recce Pharmaceuticals
- Recce secures up to A$6.05 million investment agreement with
- Recce constructs automated manufacturing facility to support
- Recce achieves milestone with volume production
- Recce Confirms Delivery by Intravenous Drip
- Appendix 4E and Financial Report
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals